Multiple Sclerosis

Biotech to the rescue

MIT professor Ram Sasisekharan's three biotech companies—Momenta Pharmaceuticals, Cerulean Pharma, and Visterra—share a similar goal. "It's about the impact we can have on patient care," says Sasisekharan, ...

Apr 28, 2014
popularity 4 / 5 (2) | comments 0

Study suggests targeting B cells may help with MS

A new study suggests that targeting B cells, which are a type of white blood cell in the immune system, may be associated with reduced disease activity for people with multiple sclerosis (MS). The study is released today ...

Apr 24, 2014
popularity not rated yet | comments 0

Latest Spotlight News

Study: Pupil size shows reliability of decisions

Te precision with which people make decisions can be predicted by measuring pupil size before they are presented with any information about the decision, according to a new study published in PLOS Computational Bi ...

Single dose of antidepressant changes the brain

A single dose of antidepressant is enough to produce dramatic changes in the functional architecture of the human brain. Brain scans taken of people before and after an acute dose of a commonly prescribed ...